Atrial Fibrillation

This channel includes news and new technology innovations for the treatment of atrial fibrillation, also referred to as AF or afib. AF is a cardiac arrhythmia caused by irregular and often rapid heart rate. It is caused by the upper chambers (the atria) beating irregularly and uncoordinated with the lower  ventricle chambers of of the heart. Symptoms include weakness with heart palpitations and shortness of breath. The conditional can lead to an increased risk of stroke and heart failure. AF episodes can cause the blood in the atria to stagnate and form clots, usually within the left atrial appendage (LAA). The clots can flow to the brain and cause a stroke. Treatments include anticoagulation therapy to dissolve clots, catheter or surgical ablation and LAA occlusion

News

January 12, 2015 — CardioFocus Inc., developer of the HeartLight Endoscopic Ablation System for the treatment of atrial ...

Home January 12, 2015
Home
News

January 12, 2015 — Medtronic Inc. announced the initiation of a randomized clinical trial in Europe to assess the ...

Home January 12, 2015
Home
Blog

As editor of DAIC, I keep a close watch on trends in cardiovascular technology and try to predict what the next big ...

Home December 31, 2014
Home
Technology

December 22, 2014 — AliveCor Inc. announced the launch of its third-generation AliveCor Heart Monitor. Now users have ...

Home December 22, 2014
Home
News

December 19, 2014 — The American College of Cardiology’s recently released Guideline Clinical App has expanded with the ...

Home December 19, 2014
Home
News

December 18, 2014 — Topera, Inc. announced that its RhythmView 3-D Mapping System received the Most Innovative New ...

Home December 18, 2014
Home
News

December 8, 2014 — Researchers at the Minneapolis Heart Institute Foundation have found that when care teams started ...

Home December 08, 2014
Home
News

December 4, 2014 — Medi?Lynx Cardiac Monitoring LLC and MEDICALgorithmics will participate in a research project ...

Home December 04, 2014
Home
AHA, warfarin, antiplatelet therapy, atrial fibrillation, anti-clotting, EP lab
Feature

November 16, 2014 — Long-term overtreatment with the anti-clotting drug warfarin, combined with antiplatelet therapy of ...

Home November 24, 2014
Home
News

November 24, 2014 — Obesity is a known risk factor for atrial fibrillation (AFib), the most common heart rhythm disorder ...

Home November 24, 2014
Home
News

Nov. 5, 2014 — Enrollment is open for the Dual Epicardial and Endocardial Procedure (DEEP) clinical trial following U.S ...

Home November 05, 2014
Home
News

October 30, 2014 — New physician experience for the Convergent Procedure in the treatment of persistent atrial ...

Home October 30, 2014
Home
Topera, Abbott, FIRMap, rotors, rotor mapping
Feature
Oct. 29, 2014 – Abbott has entered into an agreement to purchase Topera Inc., a private, venture-backed medical device ...
Home October 29, 2014
Home
Technology

October 28, 2014 — St. Jude Medical Inc. today announced U.S. Food and Drug Administration (FDA) approval of its ...

Home October 28, 2014
Home
News

October 17, 2014 – The electrophysiology service of the Massachusetts General Hospital Institute for Heart, Vascular and ...

Home October 17, 2014
Home
Subscribe Now